TABLE 3.
Controls M (SD) | Patients end of treatment M (SD) P | Patients 2-mo follow-up M (SD) P | Patients 4-mo follow-up M (SD) P | Patients 6-mo follow-up M (SD) P | |
---|---|---|---|---|---|
POMS-F | 4.51 (5.40) | 7.57 (6.54) <.0001 | 5.52 (5.55) .05 | 5.01 (5.19) .24 | 5.08 (5.57) .24 |
FSI most | 3.80 (2.60) | 4.54 (2.99) .008 | 3.41 (2.89) .16 | 3.28 (2.82) .05 | 3.14 (2.85) 01 |
FSI average | 2.38 (2.05) | 3.11 (2.41) .0009 | 2.25 (2.18) .63 | 2.19 (2.08) .43 | 2.12 (2.23) .24 |
FSI current | 1.53 (1.94) | 2.79 (2.74) <.0001 | 2.07 (2.40) .007 | 1.92 (2.31) .04 | 1.76 (2.26) .21 |
FSI days | 2.50 (2.13) | 4.28 (2.62) <.0001 | 3.05 (2.57) .009 | 3.01 (2.62) .01 | 2.92 (2.61) .04 |
FSI interference | 1.15 (1.55) | 1.74 (2.02) .0007 | 1.23 (1.67) .52 | 1.15 (1.61) .79 | 1.20 (1.76) .67 |
POMS-F indicates Profile of Mood States Fatigue Scale; FSI, Fatigue Symptom Inventory.